Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Central Nervous System Neoplasm”

713 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 713 results

Not applicableLooking for participantsNCT05954858
What this trial is testing

Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma

Who this might be right for
Glioma, MalignantGlioblastomaGlioblastoma Multiforme+4 more
Northwell Health 32
Not applicableStudy completedNCT02261649
What this trial is testing

Impact of Cerebellar Mass Resection on Pain Processing

Who this might be right for
Cerebellar Neoplasm
Dana-Farber Cancer Institute 24
Early research (Phase 1)Study completedNCT00503204
What this trial is testing

Phase I : Cediranib in Combination With Lomustine Chemotherapy in Recurrent Malignant Brain Tumour

Who this might be right for
Recurrent GlioblastomaBrain Tumor
AstraZeneca 20
Testing effectiveness (Phase 2)Study completedNCT00002931
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Germ Cell Cancer

Who this might be right for
Brain and Central Nervous System TumorsExtragonadal Germ Cell TumorOvarian Cancer+2 more
City of Hope Medical Center 48
Large-scale testing (Phase 3)Ended earlyNCT01189253
What this trial is testing

Doxorubicin Hydrochloride or Trabectedin in Treating Patients With Previously Untreated Advanced or Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
European Organisation for Research and Treatment of Cancer - EORTC 133
Testing effectiveness (Phase 2)Study completedNCT00619112
What this trial is testing

Temozolomide in Treating Patients With Recurrent High-Grade Glioma

Who this might be right for
Recurrent Central Nervous System Neoplasm
University of California, San Francisco 60
Testing effectiveness (Phase 2)UnknownNCT00492687
What this trial is testing

Radiation Therapy, Temozolomide, Tamoxifen, and Carboplatin in Treating Patients With Malignant Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
San Diego Pacific Oncology & Hematology Associates 80
Not applicableStudy completedNCT03746392
What this trial is testing

Project to Improve Communication About Serious Illness - Pilot Study

Who this might be right for
Malignant NeoplasmLeukemia, Lymphocytic, Chronic, B-CellLung Disease Chronic+7 more
University of Washington 150
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Testing effectiveness (Phase 2)Study completedNCT00062478
What this trial is testing

Study of Karenitecin (BNP1350) in Patients With Brain Tumors

Who this might be right for
Brain NeoplasmsMalignant Neoplasms, BrainBrain Tumors
BioNumerik Pharmaceuticals, Inc. 40
Early research (Phase 1)Study completedNCT04456140
What this trial is testing

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Who this might be right for
Breast CarcinomaDigestive System NeoplasmMalignant Brain Neoplasm+8 more
Mayo Clinic 230
Testing effectiveness (Phase 2)Looking for participantsNCT02896335
What this trial is testing

Palbociclib and Pembrolizumab In Central Nervous System Metastases

Who this might be right for
Metastatic Malignant Neoplasm to BrainRecurrent Brain MetastasesProgressive Brain Metastases
Massachusetts General Hospital 45
Early research (Phase 1)Study completedNCT00036959
What this trial is testing

ABT-751 in Treating Young Patients With Refractory Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more
National Institutes of Health Clinical Center (CC) 90
Early research (Phase 1)Ended earlyNCT06193174
What this trial is testing

Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)

Who this might be right for
Recurrent Malignant GliomaGlioblastoma Multiforme of BrainGliosarcoma of Brain+1 more
University of Alabama at Birmingham 1
Testing effectiveness (Phase 2)WithdrawnNCT03973879
What this trial is testing

Combination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant Glioma

Who this might be right for
Malignant Glioma
Darell Bigner
Early research (Phase 1)Study completedNCT01111097
What this trial is testing

Study of the Safety and Efficacy of Dichloroacetate (DCA) in Glioblastoma and Other Recurrent Brain Tumors

Who this might be right for
Brain TumorGlioblastoma
University of Florida 15
Testing effectiveness (Phase 2)Looking for participantsNCT03270059
What this trial is testing

Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous System

Who this might be right for
Central Nervous System NeoplasmCranial Nerve DisorderMetastatic Malignant Neoplasm in the Brain
OHSU Knight Cancer Institute 150
Early research (Phase 1)Study completedNCT01698450
What this trial is testing

Magnetic Resonance (MR) Guided Functional Ultrasound-Neurosurgery for Movement Disorders

Who this might be right for
Essential TremorDystoniaParkinson's Disease
University Children's Hospital, Zurich 10
Early research (Phase 1)Ended earlyNCT00238173
What this trial is testing

Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ+1 more
OHSU Knight Cancer Institute 2
Early research (Phase 1)WithdrawnNCT01320787
What this trial is testing

18-F-Fluoroacetate as PET Imaging Agent

Who this might be right for
Brain CancerBreast CancerProstate Cancer
M.D. Anderson Cancer Center
Load More Results